secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001356576-24-000009
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Supernus SVP Regulatory Affairs retires; successor Roman Bradel to join in March 2024
--------------------------------------------------------------------------------

- Tami T. Martin notified retirement effective May 3, 2024.
- Roman Bradel expected to join March 2024 as VP Regulatory Affairs.
- Bradel will report to Frank Mottola, SVP Quality, GMP Operations and IT.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/supn-20240214.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer